Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cleary

Showing results (231-240 of 360) with videos related to

Pageof 36
Sort By:
European Journal of Clinical Nutrition|March 9, 2006
Randomised controlled trial of essential fatty acid supplementation in phenylketonuriaM A Cleary, F Feillet, F J White, et al.
The American Naturalist|June 15, 2011
The effect of travel loss on evolutionarily stable distributions of populations in spaceDonald L Deangelis, Gail S K Wolkowicz, Yuan Lou, et al.
Synapse (New York, N.Y.)|October 9, 2004
Alteration of hippocampal cell proliferation in mice lacking the beta 2 subunit of the neuronal nicotinic acetylcholine receptorAlexia Harrist, Robert D Beech, Sarah L King, et al.
Diabetes Care|September 14, 2010
Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC studyCatherine L Martin, Barbara H Waberski, Rodica Pop-Busui, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 8, 2010
Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications studyNaji Younes, Patricia A Cleary, Michael W Steffes, et al.
Journal of Biological Response Modifiers|April 1, 1985
A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancerR S Schulof, M J Lloyd, P A Cleary, et al.
The New England Journal of Medicine|December 24, 2005
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesDavid M Nathan, Patricia A Cleary, Jye-Yu C Backlund, et al.
Urology|April 14, 2009
Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications studyAruna V Sarma, Alka Kanaya, Leroy M Nyberg, et al.
Stem Cell Reports|March 4, 2015
Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulationRoberto Narcisi, Mairéad A Cleary, Pieter A J Brama, et al.
Diabetes Care|February 13, 2010
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) StudyJames W Albers, William H Herman, Rodica Pop-Busui, et al.
Pageof 36

Showing results (231-240 of 360) with videos related to

Sort By:
Pageof 36
European Journal of Clinical Nutrition|March 9, 2006
Randomised controlled trial of essential fatty acid supplementation in phenylketonuriaM A Cleary, F Feillet, F J White, et al.
The American Naturalist|June 15, 2011
The effect of travel loss on evolutionarily stable distributions of populations in spaceDonald L Deangelis, Gail S K Wolkowicz, Yuan Lou, et al.
Synapse (New York, N.Y.)|October 9, 2004
Alteration of hippocampal cell proliferation in mice lacking the beta 2 subunit of the neuronal nicotinic acetylcholine receptorAlexia Harrist, Robert D Beech, Sarah L King, et al.
Diabetes Care|September 14, 2010
Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC studyCatherine L Martin, Barbara H Waberski, Rodica Pop-Busui, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 8, 2010
Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications studyNaji Younes, Patricia A Cleary, Michael W Steffes, et al.
Journal of Biological Response Modifiers|April 1, 1985
A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancerR S Schulof, M J Lloyd, P A Cleary, et al.
The New England Journal of Medicine|December 24, 2005
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesDavid M Nathan, Patricia A Cleary, Jye-Yu C Backlund, et al.
Urology|April 14, 2009
Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications studyAruna V Sarma, Alka Kanaya, Leroy M Nyberg, et al.
Stem Cell Reports|March 4, 2015
Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulationRoberto Narcisi, Mairéad A Cleary, Pieter A J Brama, et al.
Diabetes Care|February 13, 2010
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) StudyJames W Albers, William H Herman, Rodica Pop-Busui, et al.
Pageof 36